This review demonstrates how nanotechnology enhances bioavailability and targeting effectiveness in pharmaceuticals, indicating significant advancements in drug delivery strategies.
Nanotechnology has revolutionized the pharmaceutical sciences by offering innovative strategies for drug formulation, delivery, and diagnostics. This review offers an in-depth examination of the new trends and uses of nanotechnology in the field of pharmacy. The aim is to emphasize how nanoscale materials and systems improve the bioavailability, targeting effectiveness, and therapeutic results of pharmaceutical compounds. The methodology involves a thorough evaluation of recent literature, concentrating on different nanocarrier systems, including liposomes, solid lipid nanoparticles, dendrimers, and polymeric nanoparticles and nanoemulsions. The review also examines their roles in overcoming challenges like poor solubility, limited permeability, and non-specific distribution of conventional drugs. Key applications explored include cancer therapy, brain-targeted drug delivery, transdermal systems, and vaccine development. Furthermore, advances in nanodiagnostics and personalized nanomedicine are discussed, along with regulatory and safety considerations. The findings underscore the transformative potential of nanotechnology to reshape pharmaceutical development and therapeutics. In conclusion, continued interdisciplinary research and responsible integration of nanotechnological innovations are critical for their safe and effective translation into clinical practice.
No takes yet. Share an insight, caveat, or question.
Yadav et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: